Selective mutism is a childhood anxiety disorder defined by a consistent failure to speak in specific social situations where speech is expected, despite speaking normally elsewhere. DSM-5-TR places it within the anxiety disorders chapter, reflecting decades of phenomenological, family, and treatment-response data linking it to social anxiety disorder rather than to oppositionality or primary communication pathology.¹ Onset is typically before age five, but the diagnosis is often delayed until school entry exposes the child to demands for public speech, and untreated cases carry meaningful risk of persistent social anxiety, academic underperformance, and impaired peer relationships.^2-3 Behavioral interventions — particularly stimulus fading, shaping, and contingency management delivered in the school setting — are the foundation of treatment, with selective serotonin reuptake inhibitors reserved for moderate-to-severe or treatment-refractory cases.^4-5 The clinical bottom line: treat Selective mutism as anxiety, intervene early in the school environment, and reserve medication for cases that do not respond to a competent behavioral trial.

Selective mutism is uncommon but not rare, and prevalence estimates depend heavily on whether case ascertainment occurs at school entry — when the disorder typically becomes visible — or earlier in development.

Prevalence and demographics

• Point prevalence in school-age children is approximately 0.7-2.0%, with most large community surveys clustering near 0.7-1.0%.^2,6
• Female predominance is consistent across studies, with female-to-male ratios reported between 1.5:1 and 2.6:1.^2,6
• Onset is typically between ages 2 and 5, but recognition and referral cluster at ages 5-8 when school demands expose the symptom.^1,3
• Higher rates are observed in children from immigrant or bilingual families, attributed in part to the stress of operating in a non-dominant language; this is not itself diagnostic of selective mutism and the criteria require failure to speak in the child's first language as well.^1,7

Comorbidity

• Social anxiety disorder is comorbid in roughly two-thirds to nearly all clinically referred cases, making selective mutism widely viewed as a developmentally early expression of social anxiety.^2-3
• Other anxiety disorders (generalized anxiety, separation anxiety, specific phobia) are common.³
• Communication disorders (speech-sound disorder, language disorder) and mild expressive language delays are present in a substantial minority and warrant routine screening.^7-8
• Autism spectrum disorder co-occurs in a smaller subset; the two are distinguishable but overlap clinically and require careful differentiation (see DIFFERENTIAL DIAGNOSIS).⁷

Risk factors

• Behavioral inhibition in toddlerhood is the most consistent temperamental antecedent.^3,9
• Family history of social anxiety disorder is overrepresented, supporting a shared diathesis.³
• Bilingual or migration-related stress, while not causal, can precipitate or prolong symptoms in vulnerable children.⁷

Selective mutism is best understood as an anxiety-driven phenotype layered on a temperamental substrate of behavioral inhibition, rather than a discrete neurobiological entity with its own signature.

Neurobiology

• The disorder is conceptualized within the broader fear-circuit model implicated in social anxiety: amygdala hyperreactivity to social-evaluative stimuli, with diminished prefrontal regulatory control.^9-10
• Direct neuroimaging studies in selective mutism are sparse; the bulk of mechanistic inference is extrapolated from social anxiety disorder, where amygdala hyperactivation to faces and social cues is well replicated.¹⁰
• Speech itself is intact — the deficit is situational inhibition of vocalization, consistent with a freeze response to perceived social threat rather than a language-production lesion.⁷

Genetics

• Heritability estimates derive largely from family studies of behavioral inhibition and social anxiety, both of which show moderate genetic loading; selective-mutism-specific twin data are limited.^3,9
• A shared diathesis with social anxiety disorder is the dominant model, supported by familial aggregation of social anxiety in probands.³

Environmental and developmental factors

• Bilingual environments and immigration can act as situational stressors that unmask anxiety-driven mutism in inhibited children.⁷
• Trauma is not a typical antecedent; the older notion that selective mutism is a trauma response is not supported by current evidence and was a key reason DSM-IV reclassification was revisited.^1,3

Integrative model

• The prevailing model frames selective mutism as a developmentally early, situation-specific manifestation of social anxiety in a behaviorally inhibited child, sustained by negative reinforcement — silence reduces acute anxiety, and surrounding adults often accommodate, removing the demand for speech.^3,5

DSM-5-TR classifies selective mutism within the anxiety disorders chapter, a relocation from DSM-IV that reflected accumulating evidence linking the disorder to social anxiety rather than to oppositionality or trauma.¹

Core DSM-5-TR criteria

• Consistent failure to speak in specific social situations where speech is expected (commonly school), despite speaking in other situations such as at home with immediate family.¹
• The disturbance interferes with educational or occupational achievement, or with social communication.¹
• Duration of at least one month, not limited to the first month of school (which excludes the brief situational reticence common at school entry).¹
• Failure to speak is not attributable to lack of knowledge of, or comfort with, the spoken language required in the social situation.¹
• The disturbance is not better explained by a communication disorder (e.g., childhood-onset fluency disorder) and does not occur exclusively during the course of autism spectrum disorder, schizophrenia, or another psychotic disorder.¹

ICD-11 differences

• ICD-11 retains selective mutism (code 6B06) within the anxiety or fear-related disorders grouping, mirroring DSM-5-TR placement.¹¹
• ICD-11 wording emphasizes the consistency and situational specificity of the speech failure but is otherwise clinically congruent; no meaningful diagnostic-threshold divergence affects routine practice.¹¹

The hallmark is situational silence with preserved speech in safe contexts, often accompanied by frozen posture, averted gaze, and reliance on a small repertoire of nonverbal communication.

Typical presentation

• The child speaks freely at home with parents and siblings but is silent at school, with extended family, or with unfamiliar peers and adults.^3,7
• Onset is insidious; parents often describe the child as shy from toddlerhood, with the symptom crystallizing at preschool or kindergarten entry.³
• Nonverbal communication is often preserved: pointing, nodding, written notes, whispering to a select intermediary (commonly a parent or one trusted peer).⁷
• Physical signs at the moment of expected speech include a frozen facial expression, averted gaze, and motor stillness — distinct from the active avoidance seen in oppositional behavior.^3,7

Course over development

• Without intervention, school-based mutism can persist for years; many children eventually speak at school but retain residual social anxiety into adolescence and adulthood.^3,12
• A subset shifts from total mutism to whispered or single-word speech as anxiety partially attenuates, sometimes mistaken for resolution.³

Atypical presentations and red flags

• Mutism that begins after a period of normal school speech, or that follows an identifiable stressor with regression in other domains, should prompt evaluation for trauma, neurologic insult, or a primary mood disorder.³
• Failure to speak at home as well as outside it is not selective mutism and points toward a communication disorder, autism spectrum disorder, or a primary medical or neurologic cause.^1,7
• Loss of previously acquired language skills warrants neurologic workup including consideration of Landau-Kleffner syndrome and other acquired aphasias.⁸

The differential is short but high-stakes: misclassifying selective mutism as oppositionality leads to coercive responses that worsen outcomes, while missing a primary communication or neurologic cause delays appropriate workup.

Anxiety and developmental disorders

• Social anxiety disorder: the closest neighbor and the most common comorbidity. Selective mutism is distinguished by the categorical absence of speech in feared settings, whereas social anxiety in older children typically manifests as anxious speech with avoidance, not silence.^1,3
• Autism spectrum disorder: pervasive, cross-situational social-communication deficits including at home, with restricted interests and repetitive behaviors. A child who speaks fluently and reciprocally with parents at home is unlikely to have autism explain the silence at school.^1,7
• Communication disorders (language disorder, speech-sound disorder, childhood-onset fluency disorder): impairment is present across settings, not selectively absent in some. Mild communication disorders can coexist with selective mutism and warrant screening.^7-8
• Intellectual developmental disorder: cognitive profile and adaptive deficits are present across settings; selectively absent speech is not the presentation.¹

Medical and neurologic mimics

• Acquired aphasia (e.g., Landau-Kleffner syndrome, post-stroke, post-encephalitic): characterized by loss of previously acquired language across settings, often with EEG abnormalities or other neurologic signs.⁸
• Hearing impairment: undetected sensorineural or conductive hearing loss can mimic communicative withdrawal; audiologic testing should be routine.⁷
• Akinetic mutism and catatonia: rare in children but present with broader motor and arousal abnormalities, not setting-specific silence.⁸

Psychiatric mimics

• Major depressive disorder with psychomotor retardation: pervasive low mood, anhedonia, and global slowing rather than situational silence.¹
• Post-traumatic stress disorder: post-traumatic mutism is rare but can occur; identifiable index trauma and broader PTSD symptomatology distinguish it.¹
• Oppositional defiant disorder: refusal is active, situational based on demand rather than social threat, and accompanied by the broader pattern of defiance — a misclassification with real treatment-harm consequences.³

Assessment is multimodal: a clinical interview that may not yield direct verbal report from the child, collateral information from parents and teachers, and targeted screening for medical and developmental contributors.

History — mandatory elements

• Speech inventory by setting and person: where the child speaks, with whom, in what volume, and the situations in which speech reliably ceases.^3,7
• Developmental history: language milestones, prior speech in now-mute settings, behavioral inhibition in toddlerhood.³
• Family psychiatric history, particularly social anxiety and other anxiety disorders.³
• Bilingual exposure and immigration history; duration of exposure to the school language.⁷
• School functioning: academic performance, peer relationships, accommodations already in place.⁷

Examination and observation

• Direct observation in a low-pressure setting; expect the child not to speak during the initial interview and structure the encounter accordingly.⁷
• Parent-child interaction observation, ideally with a sibling or familiar peer present, to confirm preserved speech in safe contexts.⁷
• Audiologic and basic neurologic examination if not recently completed.^7-8

Validated rating scales

• Selective Mutism Questionnaire (SMQ): parent-rated, 17 items across school, family, and public settings; the most widely used disorder-specific instrument.¹³
• School Speech Questionnaire (SSQ): teacher-rated companion to the SMQ.¹³
• Spence Children's Anxiety Scale (SCAS) or Screen for Child Anxiety Related Disorders (SCARED) for comorbid anxiety profiling.¹⁴
• Social Responsiveness Scale (SRS-2) when autism is in the differential.⁷

Labs, imaging, and what NOT to order:

• No routine labs or imaging are required for the diagnosis; selective mutism is clinical.⁷
• Audiology is routine; speech-language pathology evaluation is recommended when communication-disorder features are present.^7-8
• Neuroimaging and EEG are reserved for atypical presentations: regression of previously acquired language, focal neurologic signs, or suspicion of acquired aphasia.⁸
• Avoid extensive metabolic, autoimmune, or genetic panels in the absence of specific clinical indicators — they consume resources and delay treatment.⁷

Behavioral therapy is the foundation of treatment, with selective serotonin reuptake inhibitors added when behavioral therapy alone is insufficient or when comorbid anxiety is severe. Coordination with the school is not optional; it is the primary venue of impairment and the primary venue of intervention.

Pharmacotherapy

• Selective serotonin reuptake inhibitors (SSRIs) are the most studied medication class. Evidence is strongest for fluoxetine, with smaller studies of sertraline and other agents; effect sizes are moderate and benefit is greatest in combination with behavioral therapy.^4,15-16
• Fluoxetine is typically initiated at low doses (e.g., 5-10 mg daily) and titrated gradually based on response and tolerability, with usual pediatric anxiety dosing in the 10-30 mg range.^4,15
• Sertraline and other SSRIs are reasonable alternatives, dosed per pediatric anxiety practice; head-to-head comparisons within selective mutism are lacking.^4,15
• Limited evidence suggests SSRIs are most useful for moderate-to-severe presentations, older children, or cases that have not responded to an adequate behavioral trial.^4,15
• Benzodiazepines, antipsychotics, and tricyclic antidepressants are not recommended; evidence is insufficient and harm-benefit balance is unfavorable in this population.⁴

Psychotherapy

• Behavioral therapy is first-line and the best-supported intervention. Core techniques include stimulus fading (gradually introducing new people or settings into a context where the child already speaks), shaping (reinforcing successive approximations from nonverbal communication to whispered speech to audible speech), and contingency management.^4-5,17
• Cognitive-behavioral therapy adapted for young children, often delivered in school-based or integrated formats, is commonly recommended; manualized programs such as social communication anxiety treatment have produced positive open-trial and small RCT results.^4,17
• Parent-mediated and teacher-mediated interventions are central — generalization to school requires direct engagement of school staff.^4-5
• Individual insight-oriented or play therapy without behavioral components is not supported as monotherapy.⁴

Neuromodulation

• No role. Neuromodulation interventions (ECT, rTMS) are not indicated for selective mutism and have no evidence base in this population.

Adjunctive

• School accommodations under an Individualized Education Program or 504 plan in U.S. settings, or equivalent supports elsewhere, can include nonverbal participation options, gradual speaking expectations, and a designated school-based intermediary.⁷
• Speech-language pathology involvement is appropriate when comorbid communication disorder is identified.^7-8
• Treatment of comorbid social anxiety, separation anxiety, or generalized anxiety follows standard pediatric anxiety care.¹⁴

The harms picture in selective mutism is dominated by SSRI class effects and the opportunity cost of delayed or coercive intervention; the disorder itself is not directly dangerous, but its sequelae are.

Common adverse effects

• SSRI-related: gastrointestinal upset, headache, sleep disturbance, behavioral activation, and sexual side effects in adolescents.¹⁵
• Behavioral therapy adverse events are rare; transient distress during exposure tasks is expected and managed within the protocol.^4-5

Serious or rare adverse effects

• SSRI class boxed warning for suicidal ideation and behavior in children, adolescents, and young adults during early treatment requires baseline counseling and close monitoring.¹⁵
• Behavioral activation and emergent irritability in young children on SSRIs, while not unique to this population, can be misattributed to the underlying anxiety and warrant explicit screening at follow-up.¹⁵

Monitoring and discontinuation

• Follow-up visits in the first 4-12 weeks of SSRI treatment should screen for suicidality, activation, and adverse effects, with subsequent visits at intervals appropriate to clinical stability.¹⁵
• SSRI discontinuation should be gradual to avoid discontinuation syndrome, particularly with shorter-half-life agents.¹⁵

Limitations of the evidence base

• The randomized evidence base is small. Most trials are underpowered, single-site, and short in follow-up.^4,16
• Long-term outcome data, particularly into adulthood, derive from naturalistic cohorts rather than prospective trials.^3,12
• Generalizability across cultural, linguistic, and educational contexts is limited; most published work comes from North American and European samples.^4,7

Selective mutism is by definition pediatric, but presentations and treatment considerations vary across developmental and contextual subgroups.

Preschool and early elementary

• Onset and recognition cluster here. Early behavioral intervention is most effective when initiated before silence becomes entrenched and reinforced over years.^3,5
• Medication is generally deferred in this age group except for severe presentations, given limited safety data and the strong response of younger children to behavioral therapy.⁴

Adolescents

• Persistent selective mutism into adolescence often coexists with established social anxiety disorder and is more refractory; combined behavioral therapy plus SSRI is commonly recommended.^3-4
• Treatment goals expand to include peer functioning, academic participation, and prevention of secondary depression.^3,12

Bilingual and immigrant children

• A grace period of several months in a new language environment is expected and not pathological; diagnosis requires failure to speak in the child's first language as well, in settings where speech is expected.^1,7
• Cultural-linguistic assessment with bilingual clinicians or interpreters is preferred when feasible.⁷

Comorbid autism spectrum disorder

• When the two co-occur, treat both: behavioral therapy targeting situational silence is feasible alongside autism-specific intervention, but speech goals are calibrated to the child's overall communication profile.⁷

Outcomes are reasonable with timely behavioral intervention and worse with delayed or absent treatment. The clinical concern is less the persistence of mutism per se and more the consolidation of social anxiety and functional impairment.

Natural history and response

• With active intervention, a majority of children achieve substantial improvement in speaking at school within 1-2 years; complete remission is variable.^5,12
• Without intervention, school-based mutism can persist for years; many children eventually speak but retain residual social anxiety into adolescence.^3,12

Long-term outcome

• Adult follow-up of selective mutism cohorts shows elevated rates of social anxiety disorder, other anxiety disorders, and depression compared to community controls.^3,12
• Functional outcomes — educational attainment, employment, peer relationships — are intermediate between unaffected peers and those with persistent severe social anxiety.¹²

Mortality and suicide risk

• Selective mutism itself does not carry direct mortality risk. Suicide risk parallels the trajectory of comorbid mood and anxiety disorders, which require independent screening, particularly in adolescence.³

Selective mutism is not typically a psychiatric emergency, but its silence can mask risk that the clinician must actively elicit through collateral and developmentally adapted assessment.

Safety in clinical encounters

• A child who will not speak with a clinician can still be at risk for suicidality, abuse, or medical emergency. Collateral history from parents, teachers, and primary care is essential, and safety screening should not be deferred merely because the child is mute in the encounter.³
• Written, drawn, or pointing-based safety screening tools allow the child to communicate distress without spoken speech.⁷

Hospitalization criteria

• Selective mutism alone is not an indication for inpatient psychiatric admission.³
• Admission is driven by comorbid conditions: severe depression with suicidality, eating disorder with medical compromise, or other standard pediatric psychiatric admission criteria.

Most disagreement in selective mutism centers on classification boundaries, the optimal timing and indication for medication, and the limited size of the randomized evidence base.

Classification and boundaries

• Whether selective mutism is best understood as a developmentally early variant of social anxiety disorder, a distinct disorder with overlapping features, or a heterogeneous category remains debated; the DSM-5-TR placement reflects the dominant but not unanimous view.^1,3
• The relationship to autism spectrum disorder in the subset of children with overlapping features is incompletely characterized and complicates treatment planning.⁷

Treatment timing and sequencing

• Guidelines and expert consensus broadly favor behavioral therapy first, but the threshold for adding an SSRI varies across clinicians and across health systems, with limited high-quality data to anchor the decision.^4-5
• The optimal duration of SSRI treatment after response, and the relapse risk on discontinuation, are not well established.^4,15

Evidence base limitations

• The disorder's low prevalence and the difficulty of randomizing young children to school-based behavioral protocols have constrained trial size and rigor.^4,16
• Long-term comparative effectiveness of behavioral therapy alone, SSRI alone, and combined treatment is not well characterized.⁴

• Selective mutism is classified within the anxiety disorders chapter of DSM-5-TR.¹
• Required duration is at least one month, not limited to the first month of school.¹
• Failure to speak must not be attributable to lack of knowledge of the spoken language.¹
• Most cases have onset before age 5 but are recognized at school entry.^1,3
• Female-to-male ratio is approximately 1.5-2.6:1.^2,6
• Comorbid social anxiety disorder is present in the majority of clinically referred cases.^2-3
• Behavioral inhibition in toddlerhood is the most consistent temperamental risk factor.^3,9
• The Selective Mutism Questionnaire is the most widely used disorder-specific rating scale.¹³
• First-line treatment is behavioral therapy, including stimulus fading, shaping, and contingency management.^4-5
• Fluoxetine is the most studied SSRI in selective mutism and is reserved for moderate-to-severe or refractory cases.^4,15-16
• All SSRIs carry a class boxed warning for suicidal ideation in children and adolescents.¹⁵
• A child who speaks fluently at home but is silent at school does not have autism spectrum disorder explaining the silence.^1,7
• ICD-11 classifies selective mutism within anxiety or fear-related disorders, congruent with DSM-5-TR.¹¹
• Coercive demands for speech worsen outcomes and can damage the therapeutic alliance.³
• Untreated selective mutism is associated with elevated rates of adult social anxiety disorder.^3,12

No external funding. No conflicts of interest declared. Peer-review status: pending.